Jimmy Sélambarom

994 total citations · 1 hit paper
20 papers, 734 citations indexed

About

Jimmy Sélambarom is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jimmy Sélambarom has authored 20 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jimmy Sélambarom's work include Chemical Synthesis and Analysis (6 papers), Mosquito-borne diseases and control (4 papers) and Fluorine in Organic Chemistry (4 papers). Jimmy Sélambarom is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Mosquito-borne diseases and control (4 papers) and Fluorine in Organic Chemistry (4 papers). Jimmy Sélambarom collaborates with scholars based in France, Réunion and Madagascar. Jimmy Sélambarom's co-authors include Philippe Gasque, Pascale Guiraud, Yosra Bedoui, Claude Giry, Marie Christine Jaffar-Bandjee, Xavier Guillot, Stéphane Ralandison, Axelle Septembre‐Malaterre, André A. Pavia and Françis Carré and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jimmy Sélambarom

20 papers receiving 713 citations

Hit Papers

Methotrexate an Old Drug with New Tricks 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jimmy Sélambarom France 12 180 174 101 89 86 20 734
Gurinder Singh India 19 202 1.1× 320 1.8× 52 0.5× 51 0.6× 37 0.4× 52 1.5k
Maria Mamani‐Matsuda France 16 269 1.5× 213 1.2× 131 1.3× 155 1.7× 64 0.7× 23 1.2k
Shing Shun Tony To Hong Kong 22 519 2.9× 64 0.4× 62 0.6× 37 0.4× 35 0.4× 40 1.2k
Avijit Sarkar India 19 206 1.1× 292 1.7× 20 0.2× 103 1.2× 42 0.5× 27 827
Shuangying Gui China 17 358 2.0× 59 0.3× 23 0.2× 116 1.3× 35 0.4× 48 880
Madhu Chopra India 19 396 2.2× 36 0.2× 59 0.6× 137 1.5× 44 0.5× 57 865
Ashraf Ali Saudi Arabia 18 309 1.7× 54 0.3× 54 0.5× 37 0.4× 19 0.2× 49 900
Said I. Ismail Jordan 18 898 5.0× 58 0.3× 99 1.0× 46 0.5× 39 0.5× 55 1.5k
Jyotsna Singh India 17 191 1.1× 43 0.2× 98 1.0× 108 1.2× 20 0.2× 68 821

Countries citing papers authored by Jimmy Sélambarom

Since Specialization
Citations

This map shows the geographic impact of Jimmy Sélambarom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimmy Sélambarom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimmy Sélambarom more than expected).

Fields of papers citing papers by Jimmy Sélambarom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimmy Sélambarom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimmy Sélambarom. The network helps show where Jimmy Sélambarom may publish in the future.

Co-authorship network of co-authors of Jimmy Sélambarom

This figure shows the co-authorship network connecting the top 25 collaborators of Jimmy Sélambarom. A scholar is included among the top collaborators of Jimmy Sélambarom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimmy Sélambarom. Jimmy Sélambarom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Septembre‐Malaterre, Axelle, et al.. (2022). Focus on the high therapeutic potentials of quercetin and its derivatives. Phytomedicine Plus. 2(1). 100220–100220. 64 indexed citations
3.
Girard-Valenciennes, Emmanuelle, et al.. (2022). Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines. Molecules. 27(16). 5080–5080. 7 indexed citations
4.
Bedoui, Yosra, et al.. (2022). Deciphering the Role of Schwann Cells in Inflammatory Peripheral Neuropathies Post Alphavirus Infection. Cells. 12(1). 100–100. 4 indexed citations
5.
Bedoui, Yosra, Axelle Septembre‐Malaterre, Claude Giry, et al.. (2021). Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya. PLoS neglected tropical diseases. 15(2). e0009115–e0009115. 15 indexed citations
6.
Septembre‐Malaterre, Axelle, Yosra Bedoui, Claude Giry, et al.. (2021). Quercetin can reduce viral RNA level of O’nyong-nyong virus and resulting innate immune cytokine responses in cultured human synovial fibroblasts. Scientific Reports. 11(1). 6369–6369. 15 indexed citations
8.
Septembre‐Malaterre, Axelle, Yosra Bedoui, Ludovic Hoarau, et al.. (2020). Artemisia annua, a Traditional Plant Brought to Light. International Journal of Molecular Sciences. 21(14). 4986–4986. 121 indexed citations
9.
Bedoui, Yosra, Xavier Guillot, Jimmy Sélambarom, et al.. (2019). Methotrexate an Old Drug with New Tricks. International Journal of Molecular Sciences. 20(20). 5023–5023. 318 indexed citations breakdown →
10.
Belarbi, Essia, Wildriss Viranaïcken, Renata Baranauskienė, et al.. (2018). In vitro comparison of three common essential oils mosquito repellents as inhibitors of the Ross River virus. PLoS ONE. 13(5). e0196757–e0196757. 13 indexed citations
11.
Bedoui, Yosra, Claude Giry, Marie‐Christine Jaffar‐Bandjee, et al.. (2018). Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses. PLoS neglected tropical diseases. 12(8). e0006634–e0006634. 16 indexed citations
12.
Sélambarom, Jimmy, et al.. (2011). A novel one-pot, two-step synthesis of N-acyl-1,3-thiazolidines and N-acyl-1,3-oxazolidines as potential double prodrugs of formaldehyde. Tetrahedron Letters. 52(13). 1444–1447. 3 indexed citations
13.
Jaffar-Bandjee, Marie Christine, Duksha Ramful, Bernard-Alex Gaüzère, et al.. (2010). Emergence and clinical insights into the pathology of Chikungunya virus infection. Expert Review of Anti-infective Therapy. 8(9). 987–996. 52 indexed citations
14.
Sélambarom, Jimmy, Jacqueline Smadja, Olivier P. Thomas, et al.. (2005). A Novel Route to Pseudoproline (ΨH,HPro)-Containing Dipeptides Building Blocks. International Journal of Peptide Research and Therapeutics. 11(4). 267–270. 7 indexed citations
15.
Sélambarom, Jimmy, Jacqueline Smadja, & André A. Pavia. (2004). Conversion of isomeric 2:3 adducts (aminoacid–formaldehyde) to N-acyl-pseudoprolines derivatives. Tetrahedron Letters. 46(4). 615–617. 4 indexed citations
17.
Sélambarom, Jimmy, et al.. (2002). Stereoelectronic control of oxazolidine ring-opening: structural and chemical evidences. Tetrahedron. 58(47). 9559–9566. 31 indexed citations
20.
Monge, Sophie, Jimmy Sélambarom, Françis Carré, et al.. (2000). Anomeric effects in non-carbohydrate compounds: conformational differences between the oxazolidine rings of a cis-fused bicyclic system. Carbohydrate Research. 328(2). 127–133. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026